Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (366)
NICE advice (1)
Quality standard (10)
Guidance programme
Guidance programme
Clinical guidelines (24)
Diagnostics guidance (5)
Health technology evaluations (14)
Highly specialised technologies guidance (6)
Interventional procedures guidance (19)
Medical technologies guidance (10)
NICE guidelines (29)
Public health guidelines (1)
Technology appraisal guidance (289)
Advice programme
Advice programme
Medtech innovation briefings (1)
Apply filters
Showing 181 to 190 of 377
Sort by
Title
Date
Apply sorting
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]
Technology appraisal guidance
TBC
Lifileucel for previously treated unresectable or metastatic melanoma ID3863
Technology appraisal guidance
10 December 2025
Linzagolix for treating symptoms of endometriosis [ID6357]
Technology appraisal guidance
4 June 2025
Lisocabtagene maraleucel for treating relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6174]
Technology appraisal guidance
TBC
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer (Review of TA909) [ID6434]
Technology appraisal guidance
18 September 2025
Low energy contact X-ray brachytherapy (the Papillon technique) for rectal cancer
Interventional procedures guidance
13 November 2025
Low-dose atropine eye drops for treating myopia in people 3 to 14 years [ID6517]
Technology appraisal guidance
TBC
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab) [ID44]
Technology appraisal guidance
TBC
Lung cancer (non-small-cell, advanced or metastatic second line) - erlotinib (in combination with bevacizumab) [ID43]
Technology appraisal guidance
TBC
Lurbinectedin for treating advanced platinum-resistant ovarian cancer ID1340
Technology appraisal guidance
TBC
Previous page
1
…
17
18
Current page
19
20
21
…
38
Page
19
of
38
Next page
Results per page
10
25
50
All
Back to top